These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32215200)

  • 21. Use of beta-blockers in atrial fibrillation.
    Kühlkamp V; Bosch R; Mewis C; Seipel L
    Am J Cardiovasc Drugs; 2002; 2(1):37-42. PubMed ID: 14727997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous catheter ablation treatment of recurring atrial arrhythmias after surgical ablation.
    Henry L; Durrani S; Hunt S; Friehling T; Tran H; Wish M; Del Negro A; Bell M; Ad N
    Ann Thorac Surg; 2010 Apr; 89(4):1227-31; discussion 1231-2. PubMed ID: 20338340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.
    Boriani G; Biffi M; Diemberger I; Martignani C; Branzi A
    Drugs; 2003; 63(14):1489-509. PubMed ID: 12834366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Management of Supraventricular Tachyarrhythmias in Patients with Pulmonary Arterial Hypertension.
    Małaczyńska-Rajpold K; Komosa A; Błaszyk K; Araszkiewicz A; Janus M; Olasińska-Wiśniewska A; Jankiewicz S; Mączyński M; Mularek-Kubzdela T
    Heart Lung Circ; 2016 May; 25(5):442-50. PubMed ID: 26643289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
    Sarubbi B; Ducceschi V; D'Andrea A; Liccardo B; Santangelo L; Iacono A
    Can J Cardiol; 1998 Oct; 14(10):1267-73. PubMed ID: 9852940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.
    Nattel S; Khairy P; Roy D; Thibault B; Guerra P; Talajic M; Dubuc M
    Drugs; 2002; 62(16):2377-97. PubMed ID: 12396229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Right ventricular dysfunction in chronic obstructive pulmonary disease. Evaluation and management.
    Klinger JR; Hill NS
    Chest; 1991 Mar; 99(3):715-23. PubMed ID: 1995228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial fibrillation and atrial flutter.
    Geraets DR; Kienzle MG
    Clin Pharm; 1993 Oct; 12(10):721-35; quiz 783-4. PubMed ID: 7903069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility.
    Singh BN
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):283-301. PubMed ID: 10090235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial flutter and fibrillation in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension in the ASPIRE registry: Comparison of rate versus rhythm control approaches.
    Sammut MA; Condliffe R; Elliot C; Hameed A; Lewis R; Kiely DG; Kyriacou A; Middleton JT; Raithatha A; Rothman A; Thompson AAR; Turner R; Charalampopoulos A
    Int J Cardiol; 2023 Jan; 371():363-370. PubMed ID: 36130620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic treatment of atrial arrhythmias.
    Kulbertus HE
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S32-5. PubMed ID: 1723115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of cor pulmonale.
    Romano PM; Peterson S
    Heart Dis; 2000; 2(6):431-7. PubMed ID: 11728294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic obstructive pulmonary disease and the early stage of cor pulmonale: A perspective in treatment with pulmonary arterial hypertension-approved drugs.
    Sakao S
    Respir Investig; 2019 Jul; 57(4):325-329. PubMed ID: 31085118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.
    Nyong J; Amit G; Adler AJ; Owolabi OO; Perel P; Prieto-Merino D; Lambiase P; Casas JP; Morillo CA
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012088. PubMed ID: 27871122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review of the management of atrial fibrillation in patients with heart failure.
    Khand AU; Rankin AC; Kaye GC; Cleland JG
    Eur Heart J; 2000 Apr; 21(8):614-32. PubMed ID: 10731399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardioversion for atrial fibrillations: not better than ventricular rate control].
    Verheugt FW
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):636-8. PubMed ID: 12712644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial Fibrillation: The New Epidemic of the Ageing World.
    Aronow WS; Banach M
    J Atr Fibrillation; 2009; 1(6):154. PubMed ID: 28496617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.